Fig. 4From: Therapeutic potential of recombinant cystatin from Schistosoma japonicum in TNBS-induced experimental colitis of miceTreatment of rSjcystatin after colitis reduced the percentage of Th1 cell population (CD4+IFNγ+) in three organs (a), increased regulatory T cells (Treg) in the MLN and LPMC (D-2,D-3). No statistical difference of the percentage of Th2 subsets (CD4+IL-4+) and Th17 subsets (CD4+IL-17A+) was noted between colitis group and TNBS-rSjcystatin group (b,c). The data were compared (*p < 0.05) (e)Back to article page